Ursodeoxycholate sodium, formerly known as Ursodeoxycholic Acid (sodium salt) and UDCA sodium, has anti-inflammatory and cytoprotective properties. UDCA sodium is a naturally occurring secondary bile acid. UDCA sodium is an FDA-approved drug for cholestatic liver disorders. References: Manley S, Ding W. Role of farnesoid X receptor and bile acids in alcoholic liver disease. Acta Pharm Sin B. 2015 Mar;5(2):158-67. doi: 10.1016/j.apsb.2014.12.011. Epub 2015 Mar 9. Review. PubMed PMID: 26579442; PubMed Central PMCID: PMC4629219.

纯度：≥98%

CAS：2898-95-5